SanBio Company Limited (TYO:4592)
Japan · Delayed Price · Currency is JPY 2,166.00
+91.00 (4.39%)
At close: Mar 6, 2026
SanBio Company Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
29
Market Cap
169.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jan 31, 2025 | - | - | - |
| Jan 31, 2024 | - | - | - |
| Jan 31, 2023 | - | - | - |
| Jan 31, 2022 | - | - | - |
| Jan 31, 2021 | - | - | - |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takara Bio | 44.15B |
| Nxera Pharma | 29.62B |
| GNI Group | 26.84B |
| PeptiDream | 18.52B |
| RaQualia Pharma | 3.98B |
| Japan Tissue Engineering | 2.26B |
| AnGes | 874.00M |
| Cuorips | 356.00M |